Associated Papers
Personalized and Tumor Informed Circulating Tumor DNA Assay for Molecular Residual Disease Monitoring of Solid Malignancies.
Liu L et al.
Medcomm, 2025
41346570 (PubMed )
Supplement: MCO2-6-e70483-s002.xlsx › Tumour_cellularity
Genomic subtypes of non-muscle-invasive bladder cancer: guiding immunotherapy decision-making for patients exposed to aristolochic acid.
Peng Y et al.
Molecular Medicine (cambridge, Mass.), 2025
40247187 (PubMed )
Supplement: 10020_2025_1199_MOESM5_ESM.xlsx › Sheet1
EHF suppresses cancer progression by inhibiting ETS1-mediated ZEB expression.
Sakamoto K et al.
Oncogenesis, 2021
Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.
Yachida S et al.
Cancer Cell, 2016
Select a paper to view details